Toll Free: 1-888-928-9744

Adamed Sp. z o.o. - Product Pipeline Review - 2014

Published: Dec, 2014 | Pages: 30 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Adamed Sp. z o.o. - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Adamed Sp. z o.o. - Product Pipeline Review - 2014', provides an overview of the Adamed Sp. z o.o.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Adamed Sp. z o.o.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Adamed Sp. z o.o. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Adamed Sp. z o.o.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Adamed Sp. z o.o.'s pipeline products

Reasons to buy

- Evaluate Adamed Sp. z o.o.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Adamed Sp. z o.o. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Adamed Sp. z o.o.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Adamed Sp. z o.o. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Adamed Sp. z o.o.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Adamed Sp. z o.o. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Adamed Sp. z o.o. Snapshot 5
Adamed Sp. z o.o. Overview 5
Key Information 5
Key Facts 5
Adamed Sp. z o.o. - Research and Development Overview 6
Key Therapeutic Areas 6
Adamed Sp. z o.o. - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Adamed Sp. z o.o. - Pipeline Products Glance 11
Adamed Sp. z o.o. - Early Stage Pipeline Products 11
Preclinical Products/Combination Treatment Modalities 11
Discovery Products/Combination Treatment Modalities 12
Adamed Sp. z o.o. - Drug Profiles 13
ADN-06 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
ADN-0965 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
ADN-1184 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
ADN-2013 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
ADN-3662 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
ADO-514 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
ADN-2157 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
ONCO-3CLA 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
Small Molecule for Schizophrenia 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
Small Molecule to Agonize mGluR2 for Anxiety Disorders 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Small Molecule to Inhibits MDM2 and MDM4 for Cancer 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
Adamed Sp. z o.o. - Pipeline Analysis 24
Adamed Sp. z o.o. - Pipeline Products by Target 24
Adamed Sp. z o.o. - Pipeline Products by Molecule Type 25
Adamed Sp. z o.o. - Pipeline Products by Mechanism of Action 26
Adamed Sp. z o.o. - Dormant Projects 27
Adamed Sp. z o.o. - Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Appendix 29
Methodology 29
Coverage 29
Secondary Research 29
Primary Research 29
Expert Panel Validation 29
Contact Us 30
Disclaimer 30
List of Tables
Adamed Sp. z o.o., Key Information 5
Adamed Sp. z o.o., Key Facts 5
Adamed Sp. z o.o. - Pipeline by Indication, 2014 8
Adamed Sp. z o.o. - Pipeline by Stage of Development, 2014 9
Adamed Sp. z o.o. - Monotherapy Products in Pipeline, 2014 10
Adamed Sp. z o.o. - Preclinical, 2014 11
Adamed Sp. z o.o. - Discovery, 2014 12
Adamed Sp. z o.o. - Pipeline by Target, 2014 24
Adamed Sp. z o.o. - Pipeline by Molecule Type, 2014 25
Adamed Sp. z o.o. - Pipeline Products by Mechanism of Action, 2014 26
Adamed Sp. z o.o. - Dormant Developmental Projects,2014 27
Adamed Sp. z o.o., Subsidiaries 28 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify